Inventor · disambiguated record
Fritz Blatter
Also filed as: BLATTER FRITZ
59 granted patents·38 pending applications·328 citations·filing 1996–2024
98Inventor score
Top patents by PatentIndex Score
97 records- 0196US9993481B2Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2016·Granted Jun 12, 2018·11 cites·20 claims
- 0295US9884857B2Salts of dasatinib in amorphous formBASF SE·Filed 2014·Granted Feb 6, 2018·19 cites·18 claims
- 0395US7868176B2Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparationACADIA PHARM INC·Filed 2005·Granted Jan 11, 2011·33 cites·16 claims
- 0495US7566714B2Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2005·Granted Jul 28, 2009·15 cites·46 claims
- 0594US8067416B2Methods and compositions for the treatment of metabolic disordersOPPENHEIMER DANIEL I·Filed 2009·Granted Nov 29, 2011·12 cites·24 claims
- 0694US7923564B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2010·Granted Apr 12, 2011·26 cites·6 claims
- 0794US7732615B2N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2005·Granted Jun 8, 2010·29 cites·24 claims
- 0893US9796721B2Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2016·Granted Oct 24, 2017·12 cites·17 claims
- 0993US9433624B2Methods and compositions for the treatment of metabolic disordersOPPENHEIMER DANIEL I·Filed 2011·Granted Sep 6, 2016·10 cites·12 claims
- 1092US8557993B2Crystalline forms of pitavastatin calciumNISSAN CHEMICAL IND LTD·Filed 2012·Granted Oct 15, 2013·10 cites·39 claims
- 1191US9556164B2Salts of Dasatinib in crystalline formBASF SE·Filed 2014·Granted Jan 31, 2017·8 cites·19 claims
- 1291US9340536B2Multicomponent crystals comprising dasatinib and selected co-crystal formersBASF SE·Filed 2013·Granted May 17, 2016·8 cites·19 claims
- 1391US8236960B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline formsTHYGESEN MIKKEL BOAS·Filed 2011·Granted Aug 7, 2012·20 cites·10 claims
- 1489US8318745B2Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochlorideMOSER RUDOLF·Filed 2009·Granted Nov 27, 2012·12 cites·22 claims
- 1588US9169262B2Crystalline salts of Asenapine with organic di-acids and tri-acidsBLATTER FRITZ·Filed 2012·Granted Oct 27, 2015·8 cites·12 claims
- 1688US2023322680A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL CORP·Filed 2023·Application pending·0 cites
- 1786US11992491B2Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl esterMERCK PATENT GMBH·Filed 2019·Granted May 28, 2024·2 cites·17 claims
- 1886US11925644B2Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl esterMERCK PATENT GMBH·Filed 2019·Granted Mar 12, 2024·2 cites·13 claims
- 1986US8841316B2Multicomponent crystalline system of rosuvastatin calcium salt and vanillinBASF SE·Filed 2014·Granted Sep 23, 2014·3 cites·1 claims
- 2084US8853405B2Crystalline forms of pitavastatin calciumNISSAN CHEMICAL IND LTD·Filed 2013·Granted Oct 7, 2014·3 cites·30 claims
- 2184US7727987B2Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochlorideMERCK EPROVA AG·Filed 2004·Granted Jun 1, 2010·18 cites·20 claims
- 2283US9303036B2Crystalline asenapine hydrochloride salt formsBLATTER FRITZ·Filed 2012·Granted Apr 5, 2016·8 cites·13 claims
- 2382US8716305B2Multicomponent crystalline system of rosuvastatin calcium salt and vanillinHAFNER ANDREAS·Filed 2012·Granted May 6, 2014·3 cites·10 claims
- 2482US2024199622A1Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2023·Application pending·0 cites
- 2582US2022169614A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL CORP·Filed 2022·Application pending·0 cites
- 2681US9567317B2Multicomponent crystalline system comprising nilotinib and selected co-crystal formersBASF SE·Filed 2013·Granted Feb 14, 2017·6 cites·21 claims
- 2780US9290452B2Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereofBASF SE·Filed 2013·Granted Mar 22, 2016·2 cites·10 claims
- 2880US8101800B25,6-dihydro-1H-pyridin-2-one compoundsTRAN CHINH V·Filed 2011·Granted Jan 24, 2012·4 cites·4 claims
- 2980US7928085B2P-toluene sulfonic acid salt of 5-amino-3-(2′-O-acetyl-3′-deoxy-β-D-ribofuranosyl)-3H-thiazole[4,5-d]pyrimidine-2-one and methods for preparationANADYS PHARMACEUTICALS INC·Filed 2007·Granted Apr 19, 2011·4 cites·10 claims
- 3079US8546602B25,6-D hydro-1H-pyridin-2-one compoundsTRAN CHINH V·Filed 2012·Granted Oct 1, 2013·3 cites·1 claims
- 3179US7932387B2Crystalline forms of rosuvastatin calcium saltBASF SE·Filed 2006·Granted Apr 26, 2011·3 cites·9 claims
- 3278US11820777B2Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2022·Granted Nov 21, 2023·0 cites·27 claims
- 3378US10167291B2Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2017·Granted Jan 1, 2019·1 cites·28 claims
- 3476US9394328B2Crystalline dapagliflozin hydrateSANDOZ AG·Filed 2012·Granted Jul 19, 2016·4 cites·15 claims
- 3576US2021002227A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL CORP·Filed 2020·Application pending·0 cites
- 3674US7777049B2Crystalline forms of Rizatriptan benzoateRATIOPHARM GMBH·Filed 2005·Granted Aug 17, 2010·1 cites·14 claims
- 3774US2020148644A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL CORP·Filed 2020·Application pending·0 cites
- 3873US11129820B2Ferroportin-inhibitor saltsVIFOR INT AG·Filed 2018·Granted Sep 28, 2021·2 cites·26 claims
- 3973US8344139B2Process for preparing crystalline polymorphic forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochlorideMERCK EPROVA AG·Filed 2010·Granted Jan 1, 2013·2 cites·19 claims
- 4073US2019256469A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL CORP·Filed 2019·Application pending·0 cites
- 4171US11059829B2Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleateACERTA PHARMA BV·Filed 2020·Granted Jul 13, 2021·0 cites·42 claims
- 4271US10640509B2Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphomaACERTA PHARMA BV·Filed 2018·Granted May 5, 2020·0 cites·20 claims
- 4371US7432380B2Crystalline form of Fluvastatin sodiumCIBA SC HOLDING AG·Filed 2004·Granted Oct 7, 2008·4 cites·8 claims
- 4471US2018346425A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL IND LTD·Filed 2018·Application pending·0 cites
- 4571US2018256582A1Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2018·Application pending·0 cites
- 4670US6329553B1Selective thermal and photooxidation of hydrocarbons in zeolites by oxygenUNIV CALIFORNIA·Filed 2000·Granted Dec 11, 2001·4 cites·27 claims
- 4770US2009182008A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL IND LTD·Filed 2008·Application pending·0 cites
- 4869US12048700B2Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acidMERCK PATENT GMBH·Filed 2021·Granted Jul 30, 2024·0 cites·22 claims
- 4969US2018029987A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL IND LTD·Filed 2017·Application pending·0 cites
- 5069US2014364614A1Crystalline forms of pitavastatin calciumNISSAN CHEMICAL IND LTD·Filed 2014·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fritz Blatter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →